4Life’s Research and Development Department has been recognized with the International Research Excellence and Citation Award for Innovative Research.
The 47th Edition of the International Research Excellence and Citation Award was presented to Dr. David Vollmer, 4Life Chief Scientific Officer, for the “Contribution and Honorable Achievement in Innovative Research” for the International Journal of Molecular Sciences article, Enhancement of NK Cell Cytotoxic Activity and Immunoregulatory Effects of a Natural Product Supplement Across a Wide Age Span: A 30-Day In Vivo Human Study.
Vollmer said, “Thanks to the mission of 4Life founder David Lisonbee, our commitment to customers is not only to conduct research about our products but publish it. This recognition provides further evidence of how 4Life distinguishes itself from competitors. I am proud of my team, as well the work they do.”
The purpose of the study was to examine whether supplementation of 4Life Transfer Factor AgePro™ modulates the functional activity of natural killer (NK) cells.
Leave a Reply